Outcome of electroconvulsive therapy by race in the consortium for research on electroconvulsive therapy multisite study

Journal of ECT

Volumn 24, Issue 2, 2008, Pages 117-121

  Williams, Mark D ^a   Rummans, Teresa ^a   Sampson, Shirlene ^a   Knapp, Rebecca ^b   Mueller, Martina ^b   Husain, Mustafa M ^c   Fink, Max ^d   Rasmussen, Keith ^a   O'Connor, Kevin ^e   Smith, Glenn ^a   Petrides, George ^d,e   Kellner, Charles H ^e,f  

^a MAYO CLINIC   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d ZUCKER HILLSIDE HOSPITAL   (United States)

^e RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Consortium for Research on Electroconvulsive Therapy; Depression; ECT; Electroconvulsive therapy; Outcome; Race

Indexed keywords

LITHIUM; NORTRIPTYLINE;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCONVULSIVE THERAPY; EUROPEAN AMERICAN; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH; OUTCOME ASSESSMENT; PSYCHOSIS; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; REMISSION; CAUCASIAN; CHI SQUARE DISTRIBUTION; DEPRESSION; ETHNOLOGY; MIDDLE AGED; MULTICENTER STUDY; NEGRO; NONPARAMETRIC TEST; STATISTICS;

AFRICAN CONTINENTAL ANCESTRY GROUP; CHI-SQUARE DISTRIBUTION; DEPRESSIVE DISORDER; ELECTROCONVULSIVE THERAPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); STATISTICS, NONPARAMETRIC;

EID: 54049147865     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e31815c6641     Document Type: Article

References (21)

1. Breslau J, Kendler K, Su M, et al. Lifetime risk and persistence of psychiatric disorders across ethnic groups in the United States. Psychol Med. 2005;35:317-327.
2. Mallinger JB, Fisher SG, Brown T, et al. Racial disparities in the use of second-generation antipsychotics for the treatment of schizophrenia. Psychiatr Serv. 2006;57:133-136.
3. Cooper LA, Gonzales JJ, Gallo JJ, et al. The acceptability of treatment for depression among African-American, Hispanic, and white primary care patients. Med Care. 2003;41:479-489.
4. Wang P, Berglund P, Kessler R. Recent care of common mental disorders in the united states: prevalence and conformance with evidence-based recommendations. J Gen Intern Med. 2000;15:284-292.
5. Reid WH, Keller S, Leatherman M, et al. ECT in Texas: 19 months of mandatory reporting. J Clin Psychiatry. 1998;59:8-13.
6. Thompson JW, Weiner RD, Myers CP. Use of ECT in the United States in 1975, 1980, and 1986. Am J Psychiatry. 1994;151:1657-1661.
7. Olfson M, Marcus S, Sackeim HA, et al. Use of ECT for the inpatient treatment of recurrent major depression. Am J Psychiatry. 1998;155: 22-29.
8. Breakey WR, Dunn GJ. Racial disparity in the use of ECT for affective disorders. Am J Psychiatry. 2004;161:1635-1641.
9. Euba R, Saiz A. A comparison of the ethnic distribution in the depressed inpatient population and in the electroconvulsive therapy clinic. J ECT. 2006;22:235-236.
10. Dawkins K, Ekstrom RD, Hill MA, et al. Ethnicity and seizure threshold. Prog Neuropsychopharmacol Biol Psychiatry. 2000;24:1289-1298.
11. O'Connor K, Knapp R, Husain M, et al. The influence of age on the response of major depression to electroconvulsive therapy: a CORE report. Am J Geriatr Psychiatry. 2001;9:382-390.
12. Kellner CH, Knapp R, Petrides G, et al. Continuation electroconvulsive therapy vs. pharmacotherapy for relapse prevention in major depression. Arch Gen Psychiatry. 2006;63:1337-1344.
13. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for Axis I DSM-IV Disorders - Patient Edition (SCID-1/P, Version 2.0). New York NY: Biometrics Research Department; 1995.
14. Williams JB. Standardizing the Hamilton Depression Rating Scale: past, present, and future. Eur Arch Psychiatry Clin Neurosci. 2001;251(suppl 2):II/6-II/12.
15. Beale MD, Kellner CH, Pritchett JT, et al. Stimulus dose-titration in ECT: a 2-year clinical experience. Convulsive Ther. 1994;10:171-176.
16. American Psychiatric Association Committee on Electroconvulsive Therapy. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging, 2nd ed. Washington DC: American Psychiatric Association; 2001.
17. Sackeim HA, Prudic J, Devanand DP, et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med. 1993;328:839-846.
18. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. J Am Med Assoc. 2001;285: 1299-1307.
19. Sackeim HA. The definition and meaning of treatment-resistant depression. J Clin Psychiatry. 2001;62(suppl 16):10-17.
20. Colenda CC, McCall WV. A statistical model predicting the seizure threshold for right unilateral ECT in 106 patients. Convulsive Ther. 1996;3-12.
21. Petrides G, Fink M, Husain M, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT. 2001;17:244-253.